Interesting to see they are talking about an IND and phase IIb study in the cholesterol lowering program. This is a change from licensing out after a phase I.
Ann: AGM Presentation by James Bonnar CEO, page-2
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.023(26.4%) |
Mkt cap ! $17.85M | |||
| Open | High | Low | Value | Volume |
| 8.8¢ | 11.5¢ | 8.8¢ | $249.0K | 2.447M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19019 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 197198 | 6 |
View Market Depth
| Last trade - 12.56pm 03/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |